$ANIP
ANI PHARMACEUTICALS INC

2016 Q3 Form 10-Q Financial Statement

#000114420417055663 Filed on November 02, 2017

View on sec.gov

Income Statement

Concept 2016 Q3
Revenue $38.53M
YoY Change 92.9%
Cost Of Revenue $16.67M
YoY Change 411.32%
Gross Profit $21.86M
YoY Change 30.78%
Gross Profit Margin 56.73%
Selling, General & Admin $6.928M
YoY Change 28.32%
% of Gross Profit 31.7%
Research & Development $1.041M
YoY Change 27.73%
% of Gross Profit 4.76%
Depreciation & Amortization $5.966M
YoY Change 191.45%
% of Gross Profit 27.3%
Operating Expenses $7.969M
YoY Change 28.24%
Operating Profit $7.921M
YoY Change -6.27%
Interest Expense -$2.856M
YoY Change 3.25%
% of Operating Profit -36.06%
Other Income/Expense, Net -$21.00K
YoY Change -25.0%
Pretax Income $5.044M
YoY Change -10.84%
Income Tax -$2.501M
% Of Pretax Income -49.58%
Net Earnings $2.543M
YoY Change -44.22%
Net Earnings / Revenue 6.6%
Basic Earnings Per Share $0.22
Diluted Earnings Per Share $0.22
COMMON SHARES
Basic Shares Outstanding 11.47M shares
Diluted Shares Outstanding 11.63M shares

Balance Sheet

Concept 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $16.20M
YoY Change -89.26%
Cash & Equivalents $16.16M
Short-Term Investments
Other Short-Term Assets $2.700M
YoY Change -73.79%
Inventory $28.30M
Prepaid Expenses
Receivables $47.50M
Other Receivables $900.0K
Total Short-Term Assets $95.50M
YoY Change -51.65%
LONG-TERM ASSETS
Property, Plant & Equipment $9.700M
YoY Change 66.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $23.40M
YoY Change 138.78%
Total Long-Term Assets $223.9M
YoY Change 161.02%
TOTAL ASSETS
Total Short-Term Assets $95.50M
Total Long-Term Assets $223.9M
Total Assets $319.4M
YoY Change 12.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.700M
YoY Change 80.77%
Accrued Expenses $21.70M
YoY Change 877.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $30.50M
YoY Change 150.21%
LONG-TERM LIABILITIES
Long-Term Debt $118.8M
YoY Change 3.13%
Other Long-Term Liabilities $1.300M
YoY Change
Total Long-Term Liabilities $120.1M
YoY Change 4.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $30.50M
Total Long-Term Liabilities $120.1M
Total Liabilities $150.5M
YoY Change 18.15%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $168.8M
YoY Change
Total Liabilities & Shareholders Equity $319.4M
YoY Change 12.75%

Cashflow Statement

Concept 2016 Q3
OPERATING ACTIVITIES
Net Income $2.543M
YoY Change -44.22%
Depreciation, Depletion And Amortization $5.966M
YoY Change 191.45%
Cash From Operating Activities $1.080M
YoY Change -89.44%
INVESTING ACTIVITIES
Capital Expenditures -$1.090M
YoY Change 41.56%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$1.090M
YoY Change -95.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.140M
YoY Change 60.56%
NET CHANGE
Cash From Operating Activities 1.080M
Cash From Investing Activities -1.090M
Cash From Financing Activities 1.140M
Net Change In Cash 1.130M
YoY Change -107.14%
FREE CASH FLOW
Cash From Operating Activities $1.080M
Capital Expenditures -$1.090M
Free Cash Flow $2.170M
YoY Change -80.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1041000 USD
CY2016Q3 us-gaap Cost Of Revenue
CostOfRevenue
16669000 USD
CY2017Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
0 USD
CY2016Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
625000 USD
CY2017Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2016Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2398000 USD
CY2017Q3 anip Accrued Government Rebates
AccruedGovernmentRebates
5755000 USD
CY2016Q4 anip Accrued Government Rebates
AccruedGovernmentRebates
5891000 USD
CY2017Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
25000000 USD
CY2016Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0 USD
CY2017Q3 us-gaap Prepaid Taxes
PrepaidTaxes
2052000 USD
CY2016Q4 us-gaap Prepaid Taxes
PrepaidTaxes
0 USD
CY2016Q3 us-gaap Costs And Expenses
CostsAndExpenses
30604000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
7921000 USD
CY2016Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2856000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5044000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2501000 USD
CY2017Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
259000 USD
CY2016Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q3 us-gaap Revenues
Revenues
48164000 USD
CY2016Q3 us-gaap Revenues
Revenues
38525000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6374000 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1654000 USD
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
CY2017Q3 us-gaap Cost Of Revenue
CostOfRevenue
21078000 USD
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2634000 USD
CY2017Q3 us-gaap Costs And Expenses
CostsAndExpenses
38833000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9331000 USD
CY2017Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-3052000 USD
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11553000 shares
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11465000 shares
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11677000 shares
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11625000 shares
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
95000 USD
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-21000 USD
us-gaap Revenues
Revenues
129556000 USD
us-gaap Revenues
Revenues
90417000 USD
us-gaap Cost Of Revenue
CostOfRevenue
58586000 USD
us-gaap Cost Of Revenue
CostOfRevenue
31874000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6419000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2771000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22695000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20460000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20906000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16531000 USD
us-gaap Costs And Expenses
CostsAndExpenses
108606000 USD
us-gaap Costs And Expenses
CostsAndExpenses
71636000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
20950000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
18781000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-9009000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8468000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
58000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-31000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11999000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10282000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3446000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5268000 USD
us-gaap Net Income Loss
NetIncomeLoss
8553000 USD
us-gaap Net Income Loss
NetIncomeLoss
5014000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11542000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11421000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11666000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11552000 shares
us-gaap Share Based Compensation
ShareBasedCompensation
4668000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4687000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5723000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5421000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16279000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
25545000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4605000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4016000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1365000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
623000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2078000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2562000 USD
anip Increase Decrease In Accrued Compensation Liabilities
IncreaseDecreaseInAccruedCompensationLiabilities
378000 USD
anip Increase Decrease In Accrued Compensation Liabilities
IncreaseDecreaseInAccruedCompensationLiabilities
238000 USD
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-4450000 USD
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
198000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1814000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2654000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
50956000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
144494000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6922000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3177000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
191000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1362000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
307000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12493000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5847000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
354000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
102000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23614000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15390000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57878000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-147671000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24932000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1247000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2500000 USD
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-840000 USD
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
6082000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-4602000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1084000 USD
anip Increase Decrease In Returned Goods Reserve
IncreaseDecreaseInReturnedGoodsReserve
2561000 USD
anip Increase Decrease In Returned Goods Reserve
IncreaseDecreaseInReturnedGoodsReserve
1451000 USD
anip Increase Decrease Accrued Government Rebates
IncreaseDecreaseAccruedGovernmentRebates
-136000 USD
anip Increase Decrease Accrued Government Rebates
IncreaseDecreaseAccruedGovernmentRebates
1820000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
25000000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9332000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-133528000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154684000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16155000 USD
anip Accrued Royalties Related To Asset Purchase
AccruedRoyaltiesRelatedToAssetPurchase
3882000 USD
anip Accrued Royalties Related To Asset Purchase
AccruedRoyaltiesRelatedToAssetPurchase
0 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32367000 USD
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
154684000 USD
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23035000 USD
CY2016Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21156000 USD
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
0 USD
CY2016Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5001000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
294000 USD
anip Payment For Treasury Stock Purchases For Restricted Stock Vestings And Forfeitures
PaymentForTreasuryStockPurchasesForRestrictedStockVestingsAndForfeitures
259000 USD
anip Payment For Treasury Stock Purchases For Restricted Stock Vestings And Forfeitures
PaymentForTreasuryStockPurchasesForRestrictedStockVestingsAndForfeitures
122000 USD
us-gaap Interest Paid Net
InterestPaidNet
2197000 USD
us-gaap Interest Paid Net
InterestPaidNet
2056000 USD
CY2017Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
143750000 USD
CY2017Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
15637000 USD
CY2017Q3 us-gaap Long Term Debt
LongTermDebt
126284000 USD
CY2016Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
143750000 USD
CY2016Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
20644000 USD
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
120643000 USD
CY2017Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1829000 USD
CY2016Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2463000 USD
CY2017Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1078000 USD
CY2016Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1078000 USD
CY2017Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1692000 USD
CY2016Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1604000 USD
CY2017Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
211000 USD
CY2016Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
211000 USD
CY2017Q3 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
143000 USD
CY2016Q3 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
58000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
3234000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
3234000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
5007000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4748000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
633000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
633000 USD
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
367000 USD
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
159000 USD
CY2017Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
30000000 USD
CY2017Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
40000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8489000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4980000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
8489000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
4980000 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
124000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
131000 shares
CY2017Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
4720000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2543000 USD
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4685000 USD
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2526000 USD
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
4685000 USD
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2526000 USD
CY2017Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
124000 shares
CY2016Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
160000 shares
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4800000 shares
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4500000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4700000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4500000 shares
CY2017Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
17807000 USD
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
14138000 USD
CY2017Q3 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
1362000 USD
CY2016Q4 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
930000 USD
CY2017Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
471000 USD
CY2016Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
174000 USD
CY2017Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
915000 USD
CY2016Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
477000 USD
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6274000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
8553000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
5014000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5387000 USD
CY2017Q3 us-gaap Depreciation
Depreciation
300000 USD
CY2016Q3 us-gaap Depreciation
Depreciation
200000 USD
us-gaap Depreciation
Depreciation
900000 USD
us-gaap Depreciation
Depreciation
700000 USD
CY2017Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
100000 USD
CY2016Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
58000 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
400000 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
200000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
189829000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
26825000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
26825000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
26343000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
24898000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
78231000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
6707000 USD
CY2017Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6800000 USD
CY2016Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5700000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15800000 USD
CY2017Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
300000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.287 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.512 pure
CY2017Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.259 pure
CY2016Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.496 pure
us-gaap Fair Value Inputs Discount Rate
FairValueInputsDiscountRate
0.15 pure
CY2017Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
32463000 USD
CY2016Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
31535000 USD
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1666667 shares
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1666667 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5203 shares
CY2016Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <b>Use of Estimates</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying unaudited interim condensed consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, allowance for doubtful accounts, accruals for chargebacks, administrative fees and rebates, government rebates, returns and other allowances, allowance for inventory obsolescence, valuation of financial instruments and intangible assets, accruals for contingent liabilities, fair value of long-lived assets, deferred taxes and valuation allowance, purchase price allocations, and the depreciable lives of long-lived assets. Because of the uncertainties inherent in such estimates, actual results may differ from those estimates. Management periodically evaluates estimates used in the preparation of the financial statements for reasonableness.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23661000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
16385000 USD
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1462000 USD
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1353000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4612000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4675000 USD
CY2017Q3 anip Percentage Of Royalties On Net Sales Of Unapproved Products
PercentageOfRoyaltiesOnNetSalesOfUnapprovedProducts
less than 1%
CY2016Q3 anip Percentage Of Royalties On Net Sales Of Unapproved Products
PercentageOfRoyaltiesOnNetSalesOfUnapprovedProducts
less than 1%
anip Percentage Of Royalties On Net Sales Of Unapproved Products
PercentageOfRoyaltiesOnNetSalesOfUnapprovedProducts
less than 1%
anip Percentage Of Royalties On Net Sales Of Unapproved Products
PercentageOfRoyaltiesOnNetSalesOfUnapprovedProducts
less than 1%
CY2017Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
238048000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
203992000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
48219000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
28200000 USD
anip Acquired Finitelived Intangible Asset Amortization Description
AcquiredFinitelivedIntangibleAssetAmortizationDescription
we are amortizing 80% of the value of the intangible assets over the first five years of useful lives of the assets and amortizing the remaining 20% of the value of the intangible assets over the second five years of useful lives of the assets.
us-gaap Interest Expense Debt
InterestExpenseDebt
8507000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
8456000 USD
CY2016Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
2835000 USD
CY2017Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
2838000 USD
CY2016Q4 us-gaap Inventory Gross
InventoryGross
26357000 USD
CY2017Q3 us-gaap Inventory Gross
InventoryGross
38949000 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
300000 USD
CY2017Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
18865000 USD
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10812000 USD
CY2017Q3 us-gaap Line Of Credit
LineOfCredit
25000000 USD

Files In Submission

Name View Source Status
0001144204-17-055663-index-headers.html Edgar Link pending
0001144204-17-055663-index.html Edgar Link pending
0001144204-17-055663.txt Edgar Link pending
0001144204-17-055663-xbrl.zip Edgar Link pending
anip-20170930.xml Edgar Link completed
anip-20170930.xsd Edgar Link pending
anip-20170930_cal.xml Edgar Link unprocessable
anip-20170930_def.xml Edgar Link unprocessable
anip-20170930_lab.xml Edgar Link unprocessable
anip-20170930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv477368_10q.htm Edgar Link pending
tv477368_ex31-1.htm Edgar Link pending
tv477368_ex31-2.htm Edgar Link pending
tv477368_ex32-1.htm Edgar Link pending